Jule Vasquez-Chávez

7PUBLICATIONS
80CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Medical mycologyImmunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Aboriginal and Torres Strait Islander midwifery and paediatrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 23, 2026
Breast cancer protective genetic variant common in women of Indigenous American genetic ancestry is a cis-eQTL for RMND1, ARMT1, and CCDC170 in HER2-enriched tumor subtypes.

|Dec 07, 2023
Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America.

Humberto Martínez-Cordero, Camila Peña, Natalia Paola Schutz

|Aug 08, 2022
Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.

Eloísa Riva, Patricio José Duarte, Bryan Valcárcel

|Jul 22, 2022
Epidemiology and Risk Factors for the Development of Infectious Complications in Newly Diagnosed Multiple Myeloma: A Multicenter Prospective Cohort Study in Latin America.

Virginia Bove, Eloísa Riva, Jule Vásquez

|Jun 02, 2022
Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women.

Valentina A Zavala, Sandro Casavilca-Zambrano, Jeannie Navarro-Vásquez

|Jul 23, 2021
Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up.

Jule Vasquez, Rossana Ruiz, Karina Aliaga

Pageof 2

Frequent Collaborators

3 joint publications

Virginia Bove

3 joint publications

Eloísa Riva

3 joint publications

Camila Peña

3 joint publications

Tatiana Vidaurre